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ABSTRACT
SoxF family members have been linked to arterio-venous
specification events and human pathological conditions, but in
contrast to Sox17 and Sox18, a detailed in vivo analysis of a Sox7
mutant model is still lacking. In this studywe generated zebrafish sox7
mutants to understand the role of Sox7 during vascular development.
By in vivo imaging of transgenic zebrafish lines we show that sox7
mutants display a short circulatory loop around the heart as a result of
aberrant connections between the lateral dorsal aorta (LDA) and
either the venous primary head sinus (PHS) or the common cardinal
vein (CCV). In situ hybridization and live observations in flt4:mCitrine
transgenic embryos revealed increased expression levels of flt4 in
arterial endothelial cells at the exact location of the aberrant vascular
connections in sox7mutants. An identical circulatory short loop could
also be observed in newly generated mutants for hey2 and efnb2.
By genetically modulating levels of sox7, hey2 and efnb2 we
demonstrate a genetic interaction of sox7 with hey2 and efnb2. The
specific spatially confined effect of loss of Sox7 function can be
rescued by overexpressing the Notch intracellular domain (NICD) in
arterial cells of sox7 mutants, placing Sox7 upstream of Notch in this
aspect of arterial development. Hence, sox7 levels are crucial in
arterial specification in conjunction with hey2 and efnb2 function, with
mutants in all three genes displaying shunt formation and an arterial
block.
KEY WORDS: Vascular development, Arterial-venous specification,
Sox7, Zebrafish
INTRODUCTION
One of the first organs that develop in the vertebrate body is the
vascular system. Abnormalities in vascular development can cause
endothelial malformations ranging from severe birth defects to mild
lesions (Brouillard and Vikkula, 2007). The vascular system
consists of endothelial cells (ECs) that become specified into
arterial, venous and lymphatic cells, eventually forming a functional
vascular system. Vascular development starts with the migration of
mesodermal-derived angioblasts, which in zebrafish are localized in
two bilaterally positioned populations in the lateral plate mesoderm.
It was recently reported that medial angioblasts start migrating
around 14 hpf (10-somite stage) and the lateral angioblasts initiate
migration to the midline around 16 hpf (15-somite stage). The
medially located angioblasts will form the arterial cells of the first
arterial vessel, the dorsal aorta (DA), and the laterally localized
angioblasts will give rise exclusively to the venous cells of the first
venous vessel: the posterior cardinal vein (PCV) (Zhong et al.,
2000; Kohli et al., 2013). Vascular endothelial growth factor (Vegf)
receptors and their ligands play crucial roles during arterial-venous
specification. Vegf receptor 3/Flt4 is initially expressed in all ECs
and becomes restricted to venous and lymphatic ECs later in
development (Kaipainen et al., 1995; Hogan et al., 2009b; van
Impel et al., 2014). Inactivation of Vegfr3 in mice has been shown to
result in decreased angiogenic sprouting and vascular network
formation (Tammela et al., 2008). Activation of Vegf receptor 2,
also expressed in ECs, by VegfA and Sonic Hedgehog (Shh)
signaling induces the PLCγ/Mek/Erk pathway and subsequently the
Notch signaling pathway (Lawson et al., 2002). Upon activation of
the Notch receptor by binding to one of its ligands (Delta-like,
Jagged), the Notch intracellular domain (NICD) is released from the
plasma membrane via proteolytic processing. The NICD
translocates to the nucleus where it can bind to Suppressor of
Hairless [Su(H)]. This complex can mediate transcription of Hairy/
Enhancer of Split (Hes) and Hes-related genes (Hey/HRT/HERP)
and the expression of ephrinB2 (efnb2) on the arterial membrane
(Lawson et al., 2001; Zhong et al., 2001). Efnb2 is a member of the
Ephrin family and is a largely arterial-specific transmembrane
protein that functions as a ligand for the venous receptor tyrosine
kinase Eph receptor B4 (Ephb4). Signaling requires cell-to-cell
contact and can be bidirectional. The reciprocal signaling between
Efnb2 and Ephb4 is crucial in arterial-venous specification (Wang
et al., 1998; Gerety et al., 1999).
Previous work has suggested a role for the SRY-related HMG
box (Sox) gene family in various aspects of vascular development
(reviewed by Francois et al., 2010). The sox gene family encodes
transcription factors and consists of 10 subgroups (SoxA-J). All
members of the Sox family contain a high mobility group box
(HMG) domain, which facilitates DNA binding in the minor groove
and mediates DNA bending (Giese et al., 1992), and contain a
transactivation domain (TAD), which activates transcription of
target genes (Hosking et al., 1995). One subgroup of the Sox family
that is of particular interest for vascular development is the SoxF
group, consisting of SOX7, SOX17 and SOX18. In vitro studies
revealed that SoxF transcription factors can bind the arterial-specific
enhancer of the Notch ligand dll4 (Sacilotto et al., 2013).
Furthermore, Sox17 has recently been shown to play a key role in
endoderm formation, hematopoietic stem cell regulation and the
acquisition of arterial identity by functioning upstream of Notch
signaling (Hudson et al., 1997; Kanai-Azuma et al., 2002; He et al.,
2011; Corada et al., 2013). Mutations in SOX18 are linked to the
human hypotrichosis-lymphedema-telangiectasia (HLT) syndrome,
in which individuals have severe lymphedema, vascular leakagesReceived 1 September 2014; Accepted 6 March 2015
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and disrupted hair follicle development (Irrthum et al., 2003). The
phenotype of mice with a truncated Sox18 protein (mutation in the
ragged opossum allele) resembles this syndrome, resulting in severe
edema, blood vessel disruption and early lethality (Pennisi et al.,
2000; James et al., 2003). On some genetic backgrounds in mice,
Sox18 is required for the differentiation of ECs in lymphatic cells by
initiating expression of Prox1 (François et al., 2008). Recent work in
zebrafish, however, has shown that sox18 is dispensable for
lymphatic specification in the fish (van Impel et al., 2014). A
simultaneous knockdown of sox7 and sox18 transcripts in zebrafish
results in disruption of arterial-venous segregation at 48 hpf,
followed by shunt formation between the DA and the PCV. sox7/
sox18 double morphants display an increase in venous markers and
a decrease of arterial markers in the DA, corroborating the
involvement of Sox7/Sox18 in arterial-venous specification
(Cermenati et al., 2008; Herpers et al., 2008; Pendeville et al.,
2008). Previous reports in zebrafish could not identify a specific
vascular function for Sox7, though these studies were limited by the
use of morpholinos (Cermenati et al., 2008; Herpers et al., 2008;
Pendeville et al., 2008). Mice lacking Sox7 die at embryonic day
10.5 due to cardiovascular failure (Wat et al., 2012); this early
lethality, together with delayed development, pericardial edema and
failure of yolk sac remodeling, precludes analysis of underlying
cellular mechanisms. To understand the specific role of Sox7 during
vascular development, we therefore generated a zebrafish sox7
mutant. Here, we demonstrate a highly specific arterial-venous
shunt phenotype in sox7 mutants and connect Sox7 function to
Hey2/Notch signaling and to Efnb2 function.
RESULTS
Blood circulation is perturbed in sox7mutant embryos
Previous observations in zebrafish demonstrated that sox7 is
expressed in ECs of the major vessels in the head and trunk, such
as the PCV and the (lateral) DA (Cermenati et al., 2008; Herpers
et al., 2008; Pendeville et al., 2008) (Fig. 1A). To assess the specific
function of Sox7, we generated sox7 mutants by targeting induced
local lesions in genomes (TILLING) (Wienholds et al., 2002). The
sox7hu5626 allele comprises a guanine-to-adenine mutation leading
to a predicted premature stop-codon (after amino acid 53) within the
HMG domain (Fig. 1B; supplementary material Fig. S1).
Sequencing of cDNA from sox7hu5626 mutant embryos did not
reveal alternative transcripts lacking the nonsense mutation
(supplementary material Fig. S2), suggesting that the sox7 allele
represents a loss-of-function situation. The overall appearance of
these mutants is normal during early development (Fig. 1C);
however, we noticed severe edema formation in mutant embryos
from 72 hpf onwards, leading to lethality by day 5. Analysis of
homozygous sox7 mutants in a kdrl:eGFP;gata1:dsRed transgenic
background revealed that the majority (59%, n=275 embryos) lack
blood circulation in the trunk from the start of circulation onwards
Fig. 1. Disrupted blood circulation in sox7 zebrafish mutants. (A) sox7 in situ hybridization of 3 dpf wild-type embryos (left panel, lateral view; right panel,
dorsal view) showing sox7 expression in all main vessels. (B) Schematic diagram of the sox7hu5626 allele with a premature stop-codon after amino acid 53
(red asterisk). HMG, high mobility group box; TAD, trans-activating domain. (C) Overall normal appearance of sox7hu5626 heterozygous sibling and homozygous
mutant at 2 dpf. (D) On average, 59% of sox7hu5626 mutants display disturbed blood flow at 2.5 dpf. Percentages of pooled embryos from four independent
experiments (total of 275 embryos). Percentages can vary substantially between different backgrounds. (E) kdrl:GFP;gata1:dsRed-positive sox7hu5626 mutants
lack functional blood circulation in the trunk, whereas heterozygous siblings have normal circulation at 2.5 dpf. Right panels: higher magnifications of boxed area.
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(Fig. 1D,E). Further analysis in different transgenic backgrounds
showed that although this phenotype could always be detected in a
fraction of homozygous sox7 mutants, the actual penetrance of the
blood circulatory defect is largely dependent on the genetic
background.
When analyzing the blood flow by making use of bright-field
movies, we could observe a very specific short loop of circulation in
the sox7mutants with no circulation in the trunk. This short loop of
circulation was never observed in sox7 siblings (supplementary
material Movies 1 and 2).
To characterize the blood circulation defect in sox7 mutants in
more detail, we performed micro-angiographies. In sox7 mutants,
the rhodamine dextran dye distribution can be detected from the
injection site within the PCV towards the beating heart; however, we
never observed distribution from the heart into the axial DA
(Fig. 2A). This indicates complete blockage of blood flow at the
Fig. 2. sox7 mutants show an altered morphology of the
LDA while displaying normal DA-PCV segregation in the
trunk. (A) Rhodamine-dextran angiograms (injected into the
PCV at the position of the arrow) of sox7hu5626 fli1a:eGFP
siblings (upper panel) and mutants (lower panel) at 2 dpf.
Insets depict the rhodamine-dextran channel of the boxed
area with higher magnification highlighting the lack of dye
uptake in the DA of sox7hu5626 mutants. (B) Transverse
sections of fli1a:eGFP-positive sox7hu5626 sibling and mutant
embryos at 2 dpf, stained with anti-GFP (green) and DAPI
(blue). In sox7hu5626 mutants, the aortic morphology is
disturbed at the position of LDA/DA fusion (arrows) while
being unaffected more anteriorly and posteriorly to this
position. For relative positions of sections, see
supplementary material Fig. S3. (C) Dorsal view of sox7hu5626
kdrl:mCherry;flt4:mCitrine sibling and mutant embryos at
2.5 dpf. Right panel kdrl:mCherry channel only. Shunt
formation (arrow) occurs in sox7hu5626mutants at the position
of LDA fusion. (L) DA, (lateral) dorsal aorta; PCV, posterior
cardinal vein; CCV, common cardinal vein.
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anterior part of the DA. Cross-sections of 48 hpf sox7 mutants
revealed a locally restricted, disrupted morphology of ECs and
defective lumen formation at the position where, in sibling embryos,
both lateral dorsal aortae (LDA) fuse to form the dorsal aorta (DA).
Both anterior and posterior to this position, the structure of the aorta
in mutant embryos appeared to be unaffected (Fig. 2B;
supplementary material Fig. S3). Subsequent analysis of sox7
mutants at 2.5 dpf in kdrl:mCherry;flt4:mCitrine transgenic
embryos, in which we could distinguish arterial and venous ECs,
revealed a direct connection between the LDA and the venous
primary head sinus (PHS) or the common cardinal vein (CCV)
(Fig. 2C). In wild-type embryos, the blood is guided from the bulbus
arteriosus (BA) and ventral aorta (VA) into either the LDA and
subsequently to the DA in the trunk, or from the VA to the primitive
internal carotid artery towards the head region. The blood from the
trunk is returned towards the heart by the posterior cardinal vein
(PCV) and the CCV, and from the head via the posterior hindbrain
channel, the anterior cardinal vein and the primary head sinus (PHS)
to the CCV and the heart. The shunt in sox7 mutants causes the
blood to circulate from the BA and VA into the LDA from where it
directly returns via the PHS and CCV to the heart without entering
the trunk region. Consistently, ectopic connections between the
LDA and the PHS and between the LDA and CCV are evident in
sox7 mutants (Fig. 3A,B), while no other abnormalities in the
development of the head vasculature could be detected (data not
shown).
To investigate the temporal relationship between the blockage of
circulation at the fusion site of both LDAs and the shunt formation
between LDA and the CCV/PHS, we performed time-lapse imaging
of kdrl:eGFP-positive sox7 mutants and siblings starting at the 20-
somite stage. In wild-type embryos, the LDA is formed by
migration of an anterior and a posterior subpopulation of ECs that
fuse and give rise to a continuous LDA on both sides of the embryo
(Siekmann et al., 2009). In sox7 mutants, we found that ECs from
the developing LDA and the CCV (called Duct of Cuvier at this
stage) formed an ectopic connection already during the formation of
both vessels and prior to the onset of circulation (Fig. 3C;
supplementary material Movies 3 and 4). This finding is
consistent with the observation that embryos displaying the short-
loop phenotype do not even transiently establish blood flow in the
trunk during early stages of development. In conclusion, these
results indicate that the shunt formation in sox7 mutants is not a
secondary phenotype caused by the blockage of blood circulation at
the fusion site of the two LDAs, but is a specific effect caused by the
lack of functional Sox7.
It was previously reported that sox7/sox18 double morphants
have multiple ectopic connections between the DA and PCV
(Cermenati et al., 2008; Herpers et al., 2008; Pendeville et al.,
2008). To exclude toxic effects of the combined morpholino
knockdown, we generated sox7;sox18 double mutants and also
found multiple shunts between the DA and PCV in our genetic
mutants, thereby fully recapitulating the morphant phenotype
(Fig. 3D). However, no ectopic connections between the DA and
PCV were observed in sox7 or sox18 single mutants (Fig. 3E) (van
Impel et al., 2014), reconfirming the strong redundancy between
both SoxF transcription factors in the trunk vasculature (Cermenati
et al., 2008; Herpers et al., 2008; Pendeville et al., 2008). In
addition, we noticed that the penetrance of the sox7−/− short loop
phenotype was enhanced by the additional loss of one copy of
sox18, whereas homozygous sox18 mutants lacking one copy of
sox7 did not establish the circulatory short loop at all (Fig. 3D; data
not shown). These results suggest a compensatory role for Sox18 in
the absence of Sox7 in the LDA; however, they also emphasize the
highly specific local requirement of normal Sox7 levels in this
specific part of the aorta.
To explore the involvement of the third SoxF family member,
Sox17, in the context of LDA development, we analyzed its
expression pattern by employing a sox17:eGFP transgenic reporter
line (Mizoguchi et al., 2008). Although sox17 is expressed in
arterial cells of the dorsal aorta and ISVs (supplementary material
Fig. S4A), we could not detect sox17:eGFP expression in the LDA
of sox7 siblings or mutants (supplementary material Fig. S4B).
Furthermore, the overall sox17:eGFP expression levels in the
arterial ECs of sox7 siblings and mutants are indistinguishable at 1
and 2 dpf (supplementary material Fig. S4A; data not shown).
Therefore, although we cannot fully exclude an involvement of
Sox17 in some aspect of LDA development, our analysis suggests
that sox17 is not expressed at the right stages within the LDA to
affect its formation, unlike sox7 and sox18, the mRNAs of which
can readily be detected in ECs of this specific vascular structure.
fms-related tyrosine kinase 4 (flt4) expression is altered in
arterial cells of sox7mutants
To assess the involvement of sox7 in vascular development, we
performed whole-mount in situ hybridization for arterial and venous
specific genes. This revealed expression of flt4, also called vegfr3,
to be upregulated in arterial cells at the location of ectopic arterio-
venous connections in most sox7 mutants at 20 hpf (Fig. 4A,D).
Vegfr3/Flt4 is a transmembrane tyrosine kinase receptor for the
ligands VegfC and VegfD, and becomes quickly restricted to only
venous and lymphatic endothelial cells (Kaipainen et al., 1995;
Joukov et al., 1996; Achen et al., 1998; Hogan et al., 2009b; van
Impel et al., 2014). We confirmed our observation of induced flt4
expression with a transgenic reporter line and found flt4:mCitrine
expression to be specifically increased in the LDA of sox7 mutants
at 26 hpf, compared with the expression in the LDA of wild-type
embryos at this time point (Fig. 4B). Expression of flt4 was also
increased in the DA and ISVs in 58% of sox7 mutants at 26 hpf
(Fig. 4C,E). Although the ectopic expression of this venous marker
would suggest differential expression of other arterial and/or venous
markers, we did not detect this for a wide range of other marker
genes (notch1b, notch3, efnb2, hey2, dll4, foxc1, sox18, dab2, nr2f2
and ephb4) in sox7 mutants at several time points (20-30 hpf)
(Fig. 4A,C; data not shown).
efnb2 and hey2 genetically interact with sox7
The spatially confined defect in sox7 mutants is a rather unique
phenotype; however, we serendipitously observed identical defects
in double mutants for efnb2a and efnb2b. Both efnb2 mutants
were generated by TILLING, and contain point-mutations leading
to predicted premature stop-codons (after amino acid 86 in
efnb2ahu3393 and amino acid 78 in efnb2bhu2971) (Fig. 5A). We
found that efnb2a as well as efnb2b single mutants do not develop
any obvious vascular defects; however, simultaneous loss of both
genes resulted in a significant increase of circulatory short-circuits
in 42% of double mutants (Fig. 5B,C). As sox7 mutants also show
only a partially penetrant phenotype, this allowed us to investigate
a possible connection between sox7 and efnb2 genes by testing for
genetic interactions and hence we generated triple mutants.
Importantly, increasing the number of loss-of-function alleles
was accompanied by an increase in the amount of embryos
displaying the short-loop phenotype. Furthermore, while all
efnb2a single mutants had normal circulation, and while only
17% of sox7 mutants exhibited the short-loop phenotype in this
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genetic background, 78% of sox7;ephb2a double mutants
developed a circulatory short-loop. This revealed a significant
increase of the short-loop phenotype when combining both
mutants and suggests a strong genetic interaction between
ephb2a and sox7 (Fig. 5D).
Hairy/enhancer-of-split related with YRPW motif 2 (hey2) is a
hes-related gene that is expressed in angioblasts from early
development onwards. Previous studies have shown that mutations
in hey2 (gridlock mutants) display ectopic arterial to venous
connections (Weinstein et al., 1995). hey2 is a downstream target of
Fig. 3. sox7mutants develop a circulatory short-loop phenotype. (A) sox7hu5626 kdrl:eGFP;gata1:dsRedmutants at 2.5 dpf with shunt formation resulting in a
circulatory short-loop (middle and right panel) in contrast to normal circulation in sox7hu5626 siblings (left panel). Middle panel depicts ectopic connection between
LDA and PHS, right panel between LDA and CCV. Lower panel depicts only gata1:dsRed with detailed schematic representation of blood flow. CCV, common
cardinal vein; LDA, lateral dorsal aorta; PHS, primary head sinus; VA, ventral aorta. (B) Schematic representation of normal blood flow in wild-type embryos
compared with the short-circuit in sox7hu5626mutants at 2.5 dpf. Dashed circles highlight the position of the heart. (A,B) Lines depict blood flow in arteries (red) and
veins (blue). (C) Stills of time-lapse movies of kdrl:eGFP-positive sox7 mutant and sibling at the time point of ectopic connection formation (see supplementary
material Movies 3 and 4). ECs of the LDA (outlined by red lines) connect to ECs of the CCV (outlined by blue lines) in the sox7 mutant at 26 hpf (yellow arrow).
(D) Quantification of the phenotypes in 3 dpf sox7hu5626;sox18hu10320 loss-of-function embryos. All sox7hu5626;sox18hu10320 double homozygous mutants have a
short-loop of circulation and shunts between DA and PCV, whereas sox7−/−sox18+/+ and sox7−/−sox18+/− embryos have no shunts between DA and PCV. The
remaining, non-shown genotypic combinations of sox7;sox18 embryos all have 100% wild-type phenotype. Bars show percentages of embryos of a
representative experiment (total of 77 embryos). (E) Hematoxylin and Eosin stained transverse (left panel) and sagittal (right panel) cross-sections of trunks of
2 dpf sox7hu5626 siblings (top) and homozygous mutants (bottom) showing normal DA-PCV segregation in both siblings and mutants (arrows).
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the Notch signaling pathway and participates in arterial cell-fate
specification (Nakagawa et al., 2000). Injections of a hey2-
morpholino (MO) recapitulated the sox7 loss-of-function phenotype
in our hands with lack of blood flow in the trunk and a circulatory
short-loop near the heart. To investigate a possible connection
between sox7 and hey2, we titrated down the injected amounts of hey2
MO so that only minor vascular defects in wild-type embryos were
evident upon injection (8%with 0.3 ng) (Fig. 6A).When injected into
the offspring of a sox7+/− in-cross, we observed an increase in the
number of embryos displaying the short-loop (37% with 0.3 ng hey2
MO, 5% in un-injected sox7+/− in-cross) (Fig. 6A). To confirm this
observation, we generated hey2 TALEN constructs targeting exon 2
upstream of the two important domains: the basic helix-loop-helix
(bHLH) DNA-binding domain and the Orange domain (which
confers specificity among the hairy/enhancer-of-split family)
(Fig. 6B). Transient hey2 TALEN mRNA injections also resulted in
the same specific circulatory defects in a subset of embryos, a
phenotype that could further be reconfirmed in stable genetic hey2
mutant embryos, again mimicking the loss of sox7 (data not shown).
When transiently injected into a sox7+/− in-cross the hey2 TALEN
mRNA resulted in a moderate increase of the short-circuit penetrance
(Fig. 6C), thereby confirming theMOdata and providing independent
support for the notion that both genes function together in arterial
specification.
Increased arterial Notch signaling suppresses the vascular
defects in sox7mutants
Recently, in vitro studies reported that SoxF transcription factors
can bind the arterial-specific enhancer of the notch ligand dll4
(Sacilotto et al., 2013). As Hey2 and Efnb2a/b have been suggested
to act downstream of Notch signaling (Lawson et al., 2001) and as
we show here that sox7 genetically interacts with both factors, we
Fig. 4. flt4 expression is altered in
arterial cells of sox7 mutants.
(A-C) sox7hu5626 siblings (upper panel) and
mutants (lower panel). (A) In situ
hybridization for sox18, hey2 and flt4
in sox7hu5626 heterozygous and mutant
embryos at 20 hpf (dorsal view). sox7hu5626
mutants display elevated flt4 expression
levels in the LDA (arrow). (B) Dorsal view of
flt4:mCitrine (flt4:mCit)-positive sox7hu5626
heterozygous and homozygous mutant at
26 hpf showing elevated mCitrine
expression in the LDA of sox7hu5626mutant
(arrow) compared with sox7hu5626 siblings.
(C) Lateral view of the trunk region of
sox7hu5626 siblings and mutants with in situ
hybridization for sox18, hey2, efnb2,
notch3 and flt4 at 24-27 hpf. sox7hu5626
mutants display higher flt4 expression in
DA and ISVs (arrows) compared with
siblings. (D) Quantification of 20-24 hpf
embryos based on their flt4 expression
levels (in situ hybridization) in the LDA.
Seventy-three percent of sox7hu5626
mutants have high expression of flt4 in LDA
region at 20 hpf (total of 30 embryos).
(E) Quantification of 24-27 hpf embryos
based on their flt4 expression levels (in
situ hybridization) in the trunk. Fifty-eight
percent of sox7hu5626 mutants have
elevated flt4 expression, which was never
observed in siblings (total of 57 embryos).
(L)DA, (lateral) dorsal aorta; (P)CV,
(posterior) cardinal vein; ISV,
intersegmental vessel.
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wondered whether the arterial defects in sox7 mutants are a
consequence of altered Notch signaling levels. We increased Notch
signaling levels in arterial ECs by expressing a UAS construct
encoding the Notch1 intracellular domain (NICD) (Scheer and
Campos-Ortega, 1999) under the control of a newly established,
arterial-specific dll4 BAC-transgenic line, the expression of which
did not appear to be altered in sox7mutant embryos (supplementary
material Fig. S5; data not shown). We found that dll4:Gal4FF;UAS:
NICD expression in sox7 mutants significantly rescued the short-
loop phenotype compared with sox7 mutants lacking the UAS:
NICD construct (3% versus 27% within the same genetic
background; n=300 embryos Fig. 6D). This demonstrates that
elevated levels of arterial Notch1 signaling are sufficient to suppress
the vascular defects in sox7 mutants providing direct in vivo
evidence for the notion that Sox7 acts upstream of Notch1 signaling
in arterial specification.
DISCUSSION
Here, we report for the first time a detailed analysis of a genetic sox7
loss-of-function model. sox7 zebrafish mutants display highly
specific, locally restricted defects within the vasculature. As sox7 is
expressed in all ECs, this suggests redundant roles for SoxF family
members and a scenario where Sox18 (and possibly Sox17) can
partially compensate for the loss of sox7 in most vascular beds. The
notion of redundancy is further supported by sox18 zebrafish
mutants not showing abnormalities during early vascular
development (van Impel et al., 2014), while combined sox7 and
sox18 loss-of-function situations display rather comprehensive
Fig. 5. efnb2a;efnb2b doublemutants develop acirculatory short-circuit phenotype and sox7 genetically interactswith efnb2a. (A) Schematic diagram of
efnb2ahu3393 and efnb2bhu2971alleles with premature stop codons (red asterisks) at amino acids 86 and 78, respectively. Eph, ephrin domain (green), Cd,
cupredoxin domain (blue). (B) Quantification of efnb2ahu3393 and efnb2bhu2971 single and double mutant phenotypes revealed circulatory short-looping in
11% of efnb2ahu3393−/−;efnb2bhu2971+/− embryos and a significant increase of short-looping in 42% of double homozygous mutants (Student’s t-test, P=0.003
compared with efnb2ahu3393−/−;efnb2bhu2971+/−). The genotype combinations not shown all displayed 100% wild-type phenotype. Bars represent combined
results of five independent experiments (total of 128 embryos). (C) Blood circulation in gata1:dsRed-positive efnb2ahu3393;efnb2bhu2971 single and double mutant
embryos at 2.5 dpf. Note normal circulation in single mutants (upper panel) and short-loop phenotype in efnb2ahu3393;efnb2hu2971 double mutants (lower panel).
Schematic representation of blood flow in double mutants (lower right panel). Lines depict blood flow in arteries (red) and veins (blue). VA, ventral aorta; PHS,
primary head sinus; CCV, common cardinal vein. (D) Combinations of sox7hu5626, efnb2ahu3393 and efnb2bhu2971 loss-of-function alleles result in increasingly
severe effects on the circulatory system. All sox7hu5626;efnb2ahu3393 double homozygous mutant embryos exhibit a significant (Student’s t-test, P=0.002)
increase in the penetrance of the short-circuit phenotype compared with the only partially penetrant sox7hu5626 single mutants or the efnb2ahu3393 single mutants
lacking the short-loop defect completely. The genotype combinations not shown all displayed 100%wild-type phenotype. Bars represent combined results of five
independent experiments (total of 507 embryos). (B,D) Embryos were analyzed at 2.5 dpf. Phenotypes classified as ‘others’ are edema, total lack of circulation
and/or shunts in trunk region.
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defects, with multiple shunts between the DA and PCV in the trunk
(Cermenati et al., 2008; Herpers et al., 2008; Pendeville et al., 2008)
(and this study, Fig. 3D). In addition, no ectopic connections
between the DA and PCV were detected in sox7−/−;sox18+/−
embryos, whereas the short loop of circulation is present, suggesting
that one copy of sox18 (possibly in conjunction with sox17
function) is able to establish normal DA-PCV segregation in the
trunk of the zebrafish. However, we showed that the additional loss
of one sox18 allele enhances the penetrance of the short-loop
phenotype in sox7 mutants, suggesting a partially overlapping
function of both transcription factors also in this specific part of the
arterial compartment. However, why these compensatory
mechanisms do not fully prevail in the LDA remains enigmatic
and suggests a unique regulation within the LDA cells. Although
the DA is formed by migration of medial angioblasts originating
from the posterior lateral plate mesoderm towards the midline, the
LDA is formed by two distinct populations of medial angioblasts
from the anterior and posterior lateral plate mesoderm that migrate
towards each other and eventually connect (Siekmann et al., 2009).
In addition, the initiation of LDA formation is slightly later (around
22-somite stage) compared with the formation of the DA (around
20-somite stage) (Siekmann et al., 2009), indicating that the
developmental program controlling LDA formation differs from the
one in other arterial ECs.
In our analysis of arterio-venous markers, only flt4 levels
appeared to be changed to a detectable level, while differential
expression of other arterial and/or venous markers in sox7 mutants
could not be observed. This could theoretically be explained by very
specific and direct signaling between sox7 and flt4. It seems more
likely, however, that the process in question is modulated by a
delicate balance of genetic interactions, where very subtle changes
in expression level (too subtle to detect by in situ hybridization) are
sufficient for severely disturbing arterio-venous patterning. This
would also explain why we did not find differential expression of
arterial markers such as the Notch target genes in sox7 mutants,
even though we demonstrate here that Sox7 can act upstream of
Notch. Furthermore, the changes in expression can be highly time-
restricted, leading to differential expression in only a short time
interval. Although our in situ hybridization analysis was performed
at 30 min intervals (between 20 and 30 hpf ), it is still possible that
differential expression (possibly also only at the protein level) in
even a shorter time-interval can lead to severe disturbances in AV
patterning.
Like all other Vegf receptors, flt4 is initially expressed widely
throughout all vascular beds, with its expression in the trunk
becoming restricted to venous cells after 26 hpf in zebrafish (Hogan
et al., 2009b). Hence, a plausible scenario is that the ectopic flt4
expression in arterial cells of sox7 mutants results from a lack of
proper downregulation of flt4 specifically in these arterial cells. Flt4
and its ligands VegfC and VegfD have been shown to be involved in
endothelial cell sprouting and migration (Karkkainen et al., 2004;
Tammela et al., 2008; Hogan et al., 2009b; Villefranc et al., 2013). It
is therefore a possibility that the elevated flt4 levels in the arterial
cells of the sox7 mutants result in a disrupted balance between Flt4
signaling levels in ECs of the LDA and the surrounding venous
vessels, which in conjunction with a potential mis-regulation of
other arterial and venous patterning genes causes misguidance of
ECs and the formation of ectopic shunts.
Fig. 6. sox7 synergizes with hey2 and functions upstream of Notch ICD in LDA development. (A) The partially penetrant short-loop phenotype of both
sox7hu5626mutants (n=104) and hey2morphants (0.3 ng, n=63) is exacerbated when the hey2MO is injected into a sox7hu5626+/− in-cross (n=35). Bars show the
percentage of embryos from a representative experiment. (B) Schematic diagram of Hey2, indicating the TALEN target site in exon 2, which is upstream of the
coding region of the basic helix-loop-helix (bHLH) DNA-binding domain and the orange (Or) domain. (C) Transient injections of 10 pg per embryo hey2 TALEN
mRNA into wild-type and sox7hu5626 heterozygous in-cross. There is a moderate enhancement of penetrance of the short-loop phenotype in sox7hu5626 in-cross
injected with hey2 TALEN (n=140 embryos) compared with un-injected sox7hu5626 in-cross (n=100 embryos) and hey2 TALEN injections into wild-type embryos
(n=90 embryos). (D) Arterial specific UAS:NICD overexpression using the dll4:Gal4 driver line significantly (Student’s t-test, P=0.004) rescues the short-loop
circulatory phenotype in sox7 mutants: short-loop phenotype in 27% of mutants without NICD overexpression (n=69 embryos) and in 3% with NICD
overexpression (n=44 embryos). Bars represent pooled embryos of three independent experiments (total of 300 embryos). (A,C,D) Embryos were analyzed at
2.5 dpf. Phenotypes classified as ‘others’ are edema, total lack of circulation and/or shunts in trunk region.
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On the other hand, previous work in mice and cultured ECs
demonstrated that Efnb2 can mediate the internalization and thereby
contribute to the signaling activity of Flt4 (Wang et al., 2010). As
we show here that efnb2 functions together with sox7 and both
genes are essential for proper LDA development, the lack of efnb2
(and potentially indirectly also of sox7) could also result in reduced
internalization of Flt4 and therefore to a decrease in its signaling
potential. It is plausible that the embryo would react to such a
decrease in Flt4 signaling activity by increasing the expression of
the receptor. Hence, the elevated mRNA levels of flt4 in sox7
mutants could also hint towards a compensation mechanism rather
than being a sign of increased Flt4 signaling levels in LDA cells.
This would make the elevated flt4 mRNA levels a consequence of
the sox7 defects instead of being the actual cause of the shunt
formation.
The very specific circulatory defects in sox7, hey2 and efnb2
mutants, together with the genetic interaction study presented
here strongly suggest a synergistic relationship between sox7 and
both hey2 and efnb2. Whether these proteins function in one
pathway or in parallel pathways that synergize to function in arterial
development remains unclear at present. We suggest a model
where Sox7 (and in a partially redundant manner Sox18) acts
upstream of the Notch signaling pathway while controlling flt4
expression and potentially other arterio-venous patterning
genes, and functioning in conjunction with Hey2 and Efnb2 in
arterio-venous specification.
The locally restricted effect of the sox7mutation indicates a level
of redundancy in terms of the activity of SoxF family members to a
degree that leads, for example, to AV defects in the trunk only upon
severe reduction of both Sox7 and Sox18 (Herpers et al., 2008; this
study). All endothelial cells appear to be able to compensate for the
loss of Sox18 function (van Impel, 2014), and most endothelial
cells can compensate for loss of Sox7 (this study) – the only
exception being the endothelial cells of the LDA, which crucially
depend on Sox7 function. It is unclear at present why the LDA
represents a vascular bed that displays this specific requirement,
but the occurrence of the same locally restricted phenotype in
three different mutant scenarios indeed points towards unique
features in the genetic control of endothelial cell behavior within
the LDA.
MATERIALS AND METHODS
Zebrafish
Zebrafish were maintained under standard husbandry conditions according
to the rules of the Animal Experimentation Committee (DEC) of the
KNAW. Transgenic lines used were Tg(fli1a:eGFP)y1 (Lawson and
Weinstein, 2002), Tg(kdrl:eGFP)s843 (Jin et al., 2005), Tg(gata1:
dsRed)sd2 (Traver et al., 2003), Tg(kdrl:HRAS-mCherry)s916(Hogan et al.,
2009a), Tg(flt4:mCitrine)hu7135 (van Impel et al., 2014), Tg(Sox17:eGFP)
(Mizoguchi et al., 2008) and Tg(UAS:myc-NICD) (Scheer and Campos-
Ortega, 1999). The Tg(dll4:Gal4FFhu10049) line was generated from BAC
CH211-19M2 following standard recombineering procedures (Bussmann
and Schulte-Merker, 2011). The sox18hu10320 allele has been previously
described (van Impel et al., 2014).
Genotyping, morpholinos and TALEN constructs
Genotyping of sox7, efnb2a and efnb2b was performed by KASPAR with
primers listed in supplementary material Table S1. The hey2 MO used was
5′-CGCGCAGGTACAGACACCAAAAACT-3′ (GeneTools) (Zhong et al.,
2001); 0.3 ng of hey2 MO was used for suboptimal effect. hey2 TALEN
binding sites are: TAL1, 5′-TGTCGTTGTAGGTGAGCCA-3′; TAL2,
5′-TATTCCCAGCCAAAGCAATGG-3′; primers are mentioned in
supplementary material Table S1. Talen constructs were generated as
described previously (Cermak et al., 2011; Bedell et al., 2012).
Histology and in situ hybridization
In situ hybridization and immunohistochemistry were performed as
described previously (Schulte-Merker, 2002). For immunohistochemistry,
the embryos were stained with rabbit anti-GFP 1:1000 and anti-rabbit Alexa
488 1:1000 (Invitrogen), or stained with Hematoxylin and Eosin. The
embryos were paraffin-embedded and sectioned (7 µm), after which they
were analyzed with a Leica TCS SPE. For in situ hybridization we used
previously described hey2 (Zhong et al., 2000), sox18 (Herpers et al., 2008),
efnb2 (Chan et al., 2001), notch3 (Lawson et al., 2001) and flt4 (Bussmann
et al., 2007) probes.
Microscopy
Confocal imaging was performed on live embryos embedded in 0.5% low
melting point agarose (Invitrogen) with MS222 (0.04%) and 1-phenyl-2-
thiourea (PTU 0.003%) using a Leica TCS SPE. Bright-field pictures and
movies were acquired on a Zeiss Axioplan microscope and a Leica TCS
SPE, respectively. Images were processed using Adobe Photoshop CS5.1
and Fiji (http://fiji.sc/Fiji).
Micro-angiography
Micro-angiographywas performed by injecting rhodamine dextran (10 mg/ml)
into the PCV of MS222-anaesthetized embryos, as described previously
(Weinstein et al., 1995). Embryos were mounted in 0.5% low melting-point
agarose and imaged with a Leica TCS SPE.
RT-PCR analysis
sox7 siblings and sox7 mutants were first selected based on the short-loop
phenotype and pooled separately (n=10 embryos/pool) at 2 dpf. cDNAwas
synthesized from RNA with primers listed in supplementary material
Table S1.
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